(888) 645-1617

Tess Schulman, PhDExpert Contributor

Tess Schulman


  • Essure Permanent Birth Control Device
  • Trained Patient Advocate, National Center for Health Research
  • Grassroots Lobbyist for Medical Device Health Policy


  • Lobbied for The E-Free Act of 2015 (H.R. 3920)
  • Lobbied for The Medical Device Safety Act of 2017 (H.R. 2164)
  • Lobbied for The Medical Device Guardians Act of 2017 (H.R. 2163)


  • Paralegal Certification, Meredith College
  • PhD in Computational Chemistry, Oklahoma State University
  • BS in Chemistry & Physics, Berry College, Mount Berry, Georgia


  • Paranatrix Consulting 2001 Elizabeth Court Clayton, North Carolina 27520-8819
  • 919-297-8711

In May 2009, Tess Schulman was implanted with the Essure medical device, a permanent female contraceptive, and subsequently developed severe adverse reactions that were irreversible and life changing. After a 6-year struggle to receive a correct diagnosis from a variety of specialists, she now uses her own health journey to raise awareness, share knowledge and help other patients who have been harmed by the device.

As a member of the Essure Problems group, she volunteers as a grassroots lobbyist in Washington D.C. and her home state of North Carolina. As a lobbyist, she emphasizes the need for rigorous science in clinical trials, improved post-market surveillance, manufacturer accountability and better communication between physicians and patients regarding informed consent about the risks versus rewards of devices like Essure.

Since 2015, her lobbying efforts in D.C. have resulted in three pieces of legislation aimed at medical devices and stronger protections for consumers: The E-Free Act of 2015 (H.R. 3920), The Medical Device Safety Act of 2017 (H.R. 2164) and The Medical Device Guardians Act of 2017 (H.R. 2163).

“Drugwatch strives to present easily consumable information about potentially harmful devices like Essure to patients. We don’t have many patient-focused resources for consumers once negative trends for devices and drugs become obvious, so services like Drugwatch are invaluable for patient advocates like me. It gives us a voice and a larger audience.”

– Tess Schulman, PhD, Expert Contributor

In addition to her political activism, Schulman leverages social media to amplify her voice, connect with peers and build community among Essure patients. She serves as an administrator of the Carolina E-Sisters Group and the Post-Essure Autoimmune Symptoms (PEAS) group on Facebook, assisting other women suffering with the device and connecting them with the resources they need to get proper diagnosis and removal.

Schulman completed patient advocacy training in 2016 through the National Center for Health Research in Washington, D.C. and currently collaborates with other patients harmed by any FDA-approved medical device.

A native of Georgia, Schulman is a formally trained scientist. She received her bachelor of science in chemistry and physics from Berry College in Mount Berry, Georgia and completed doctoral studies in computational chemistry from Oklahoma State University in Stillwater, Oklahoma. With a passion for research and a fascination with the intersection of science & law, she later earned her paralegal certification from Meredith College in Raleigh, North Carolina and now works on a consulting basis for individuals, law firms, and corporations who need scientific expertise and legal research acumen.


Essure: Suspended in Brazil, Business as Usual in the USA

Essure, a permanent birth control device manufactured by Bayer, was recently recalled by a Brazilian regulatory agency yet remains available in the U.S.

Learn More